Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Gilead Sciences EBITDA 2010-2024 | GILD

Gilead Sciences annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Gilead Sciences EBITDA for the quarter ending March 31, 2024 was $-3.632B, a 254.95% decline year-over-year.
  • Gilead Sciences EBITDA for the twelve months ending March 31, 2024 was $4.322B, a 60.9% decline year-over-year.
  • Gilead Sciences 2023 annual EBITDA was $10.298B, a 9.17% increase from 2022.
  • Gilead Sciences 2022 annual EBITDA was $9.433B, a 21.18% decline from 2021.
  • Gilead Sciences 2021 annual EBITDA was $11.968B, a 115.6% increase from 2020.
  
Gilead Sciences Annual EBITDA
(Millions of US $)
2023 $10,298
2022 $9,433
2021 $11,968
2020 $5,551
2019 $5,691
2018 $9,629
2017 $15,410
2016 $18,791
2015 $23,291
2014 $16,315
2013 $4,869
2012 $4,288
2011 $4,092
2010 $4,228
2009 $3,742
Gilead Sciences Quarterly EBITDA
(Millions of US $)
2024-03-31 $-3,632
2023-12-31 $2,301
2023-09-30 $3,307
2023-06-30 $2,346
2023-03-31 $2,344
2022-12-31 $2,795
2022-09-30 $3,362
2022-06-30 $2,554
2022-03-31 $722
2021-12-31 $1,475
2021-09-30 $4,365
2021-06-30 $2,765
2021-03-31 $3,363
2020-12-31 $3,078
2020-09-30 $2,356
2020-06-30 $-2,634
2020-03-31 $2,751
2019-12-31 $1,443
2019-09-30 $-1,126
2019-06-30 $2,778
2019-03-31 $2,596
2018-12-31 $1,502
2018-09-30 $2,981
2018-06-30 $2,636
2018-03-31 $2,510
2017-12-31 $2,688
2017-09-30 $4,109
2017-06-30 $4,552
2017-03-31 $4,061
2016-12-31 $4,337
2016-09-30 $4,698
2016-06-30 $4,822
2016-03-31 $4,934
2015-12-31 $5,899
2015-09-30 $5,863
2015-06-30 $5,889
2015-03-31 $5,640
2014-12-31 $4,605
2014-09-30 $3,748
2014-06-30 $4,678
2014-03-31 $3,284
2013-12-31 $1,325
2013-09-30 $1,217
2013-06-30 $1,227
2013-03-31 $1,100
2012-12-31 $1,180
2012-09-30 $1,115
2012-06-30 $1,127
2012-03-31 $866
2011-12-31 $941
2011-09-30 $1,077
2011-06-30 $1,092
2011-03-31 $983
2010-12-31 $907
2010-09-30 $1,048
2010-06-30 $1,051
2010-03-31 $1,221
2009-12-31 $1,130
2009-09-30 $951
2009-06-30 $814
2009-03-31 $847
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $95.943B $27.116B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $179.625B 17.97
Vertex Pharmaceuticals (VRTX) United States $127.803B 32.89
Regeneron Pharmaceuticals (REGN) United States $118.850B 29.07
Bristol Myers Squibb (BMY) United States $102.267B 36.82
CSL (CSLLY) Australia $98.149B 0.00
GSK (GSK) United Kingdom $82.611B 9.87
Moderna (MRNA) United States $46.797B 0.00
Biogen (BIIB) United States $30.746B 14.08
Alnylam Pharmaceuticals (ALNY) United States $29.705B 0.00
Argenex SE (ARGX) Netherlands $29.386B 0.00
BioNTech SE (BNTX) Germany $20.430B 171.88
Illumina (ILMN) United States $19.185B 136.85
Genmab (GMAB) Denmark $18.770B 22.00
BioMarin Pharmaceutical (BMRN) United States $16.062B 62.66
BeiGene (BGNE) Cayman Islands $15.760B 0.00
Incyte (INCY) United States $15.406B 23.82
Sarepta Therapeutics (SRPT) United States $13.634B 1202.00
Bio-Techne Corp (TECH) United States $12.701B 47.98
Insmed (INSM) United States $11.077B 0.00
Legend Biotech (LEGN) United States $10.319B 0.00
QIAGEN (QGEN) Netherlands $10.027B 21.42
Vaxcyte (PCVX) United States $9.144B 0.00
Intra-Cellular Therapies (ITCI) United States $8.487B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.393B 27.45
Exact Sciences (EXAS) United States $8.359B 0.00
Roivant Sciences (ROIV) United Kingdom $7.978B 0.00
Repligen (RGEN) United States $7.867B 102.77
Ascendis Pharma (ASND) Denmark $7.788B 0.00
Viking Therapeutics (VKTX) United States $7.310B 0.00
Halozyme Therapeutics (HALO) United States $7.157B 19.87
Exelixis (EXEL) United States $7.092B 36.55
Blueprint Medicines (BPMC) United States $7.025B 0.00
Zealand Pharma (ZLDPF) Denmark $6.658B 0.00
Cytokinetics (CYTK) United States $6.259B 0.00
Krystal Biotech (KRYS) United States $6.102B 0.00
Nuvalent (NUVL) United States $5.268B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.918B 0.00
Apellis Pharmaceuticals (APLS) United States $4.824B 0.00
Avidity Biosciences (RNA) United States $4.604B 0.00
Alkermes (ALKS) Ireland $4.591B 16.12
Immunovant (IMVT) United States $4.254B 0.00
Axsome Therapeutics (AXSM) United States $4.110B 0.00
Guardant Health (GH) United States $4.038B 0.00
ImmunityBio (IBRX) United States $3.880B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.729B 0.00
Biohaven (BHVN) United States $3.639B 0.00
Arcellx (ACLX) United States $3.446B 0.00
Denali Therapeutics (DNLI) United States $3.437B 0.00
Twist Bioscience (TWST) United States $3.382B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.318B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.234B 0.00
IDEAYA Biosciences (IDYA) United States $3.208B 0.00
Merus (MRUS) Netherlands $3.180B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.162B 0.00
ADMA Biologics Inc (ADMA) United States $3.051B 119.64
Amicus Therapeutics (FOLD) United States $3.015B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.991B 0.00
Celldex Therapeutics (CLDX) United States $2.937B 0.00
Apogee Therapeutics (APGE) United States $2.920B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.860B 0.00
Morphic Holding (MORF) United States $2.833B 0.00
SpringWorks Therapeutics (SWTX) United States $2.818B 0.00
MorphoSys AG (MOR) Germany $2.773B 0.00
Geron (GERN) United States $2.764B 0.00
Kymera Therapeutics (KYMR) United States $2.733B 0.00
Beam Therapeutics (BEAM) United States $2.728B 0.00
Iovance Biotherapeutics (IOVA) United States $2.588B 0.00
Intellia Therapeutics (NTLA) United States $2.557B 0.00
Vericel (VCEL) United States $2.543B 0.00
Certara (CERT) United States $2.528B 58.22
Myriad Genetics (MYGN) United States $2.503B 0.00
Fortrea Holdings (FTRE) United States $2.407B 29.58
Novavax (NVAX) United States $2.402B 0.00
Protagonist Therapeutics (PTGX) United States $2.363B 16.51
Rocket Pharmaceuticals (RCKT) United States $2.300B 0.00
Janux Therapeutics (JANX) United States $2.281B 0.00
CG Oncology (CGON) United States $2.204B 0.00
Syndax Pharmaceuticals (SNDX) United States $2.081B 0.00
Neumora Therapeutics (NMRA) United States $2.058B 0.00
Bavarian Nordic (BVNRY) Denmark $2.055B 8.95
NovoCure (NVCR) Jersey $2.047B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.042B 0.00
Arvinas (ARVN) United States $2.029B 0.00
Vera Therapeutics (VERA) United States $2.008B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.007B 0.00
Akero Therapeutics (AKRO) United States $1.945B 0.00
Ligand Pharmaceuticals (LGND) United States $1.929B 31.51
Harmony Biosciences Holdings (HRMY) United States $1.926B 14.68
NeoGenomics (NEO) United States $1.900B 0.00
Keros Therapeutics (KROS) United States $1.888B 0.00
Zai Lab (ZLAB) China $1.879B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.853B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.837B 0.00
Galapagos (GLPG) Belgium $1.811B 0.00
Structure Therapeutics (GPCR) United States $1.802B 0.00
Edgewise Therapeutics (EWTX) United States $1.773B 0.00
Kura Oncology (KURA) United States $1.607B 0.00
MannKind (MNKD) United States $1.593B 195.00
Dynavax Technologies (DVAX) United States $1.520B 193.50
Belite Bio (BLTE) United States $1.464B 0.00
Vir Biotechnology (VIR) United States $1.456B 0.00
Longboard Pharmaceuticals (LBPH) United States $1.454B 0.00
Arcus Biosciences (RCUS) United States $1.438B 0.00
Sana Biotechnology (SANA) United States $1.418B 0.00
Nurix Therapeutics (NRIX) United States $1.413B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.401B 0.00
ANI Pharmaceuticals (ANIP) United States $1.327B 16.47
Prothena (PRTA) Ireland $1.314B 0.00
Gyre Therapeutics (GYRE) United States $1.284B 0.00
Spyre Therapeutics (SYRE) United States $1.268B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.242B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.166B 0.00
Cullinan Therapeutics (CGEM) United States $1.162B 0.00
MiMedx (MDXG) United States $1.145B 48.50
Disc Medicine (IRON) United States $1.129B 0.00
Viridian Therapeutics (VRDN) United States $1.063B 0.00
Tyra Biosciences (TYRA) United States $1.056B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.049B 0.00
Tango Therapeutics (TNGX) United States $1.042B 0.00
Immatics (IMTX) Germany $1.041B 0.00
AnaptysBio (ANAB) United States $1.012B 0.00
Immunome (IMNM) United States $0.990B 0.00
Praxis Precision Medicines (PRAX) United States $0.987B 0.00
AbCellera Biologics (ABCL) Canada $0.959B 0.00
Humacyte (HUMA) United States $0.946B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.945B 0.00
Nuvation Bio (NUVB) United States $0.924B 0.00
Cogent Biosciences (COGT) United States $0.910B 0.00
89BIO (ETNB) United States $0.909B 0.00
Liquidia Technologies (LQDA) United States $0.889B 0.00
Cytek Biosciences (CTKB) United States $0.883B 0.00
Olema Pharmaceuticals (OLMA) United States $0.863B 0.00
Dianthus Therapeutics (DNTH) United States $0.850B 0.00
Mesoblast (MESO) Australia $0.845B 0.00
CureVac (CVAC) Germany $0.833B 0.00
Stoke Therapeutics (STOK) United States $0.827B 0.00
CARGO Therapeutics (CRGX) United States $0.819B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.819B 0.00
Rapport Therapeutics (RAPP) $0.815B 0.00
Pliant Therapeutics (PLRX) United States $0.807B 0.00
Oric Pharmaceuticals (ORIC) United States $0.802B 0.00
WAVE Life Sciences (WVE) Singapore $0.800B 0.00
Tectonic Therapeutic (TECX) United States $0.792B 0.00
Zymeworks (ZYME) United States $0.760B 0.00
Travere Therapeutics (TVTX) United States $0.753B 0.00
ArriVent BioPharma (AVBP) United States $0.750B 0.00
Abivax SA (ABVX) France $0.746B 0.00
Scholar Rock Holding (SRRK) United States $0.740B 0.00
Arbutus Biopharma (ABUS) United States $0.736B 0.00
Emergent Biosolutions (EBS) United States $0.732B 0.00
Replimune (REPL) United States $0.707B 0.00
REGENXBIO (RGNX) United States $0.706B 0.00
ACELYRIN, INC (SLRN) United States $0.693B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.687B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.675B 0.00
Prime Medicine (PRME) United States $0.673B 0.00
Mineralys Therapeutics (MLYS) United States $0.668B 0.00
Adaptive Biotechnologies (ADPT) United States $0.665B 0.00
IGM Biosciences (IGMS) United States $0.660B 0.00
Celcuity (CELC) United States $0.657B 0.00
Astria Therapeutics (ATXS) United States $0.655B 0.00
Avid Bioservices (CDMO) United States $0.650B 0.00
GH Research (GHRS) Ireland $0.650B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Allogene Therapeutics (ALLO) United States $0.627B 0.00
Alector (ALEC) United States $0.626B 0.00
ITeos Therapeutics (ITOS) United States $0.622B 0.00
Fate Therapeutics (FATE) United States $0.619B 0.00
PepGen (PEPG) United States $0.601B 0.00
Applied Therapeutics (APLT) United States $0.596B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.589B 0.00
Alumis (ALMS) United States $0.583B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.583B 0.00
Terns Pharmaceuticals (TERN) United States $0.583B 0.00
Neurogene (NGNE) United States $0.582B 0.00
Castle Biosciences (CSTL) United States $0.581B 0.00
Entrada Therapeutics (TRDA) United States $0.581B 27.33
Annexon (ANNX) United States $0.577B 0.00
Anavex Life Sciences (AVXL) United States $0.570B 0.00
Erasca (ERAS) United States $0.569B 0.00
Fulcrum Therapeutics (FULC) United States $0.552B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.550B 0.00
Pharming Group (PHAR) Netherlands $0.542B 0.00
Contineum Therapeutics (CTNM) United States $0.540B 0.00
PureTech Health (PRTC) United States $0.539B 0.00
Aura Biosciences (AURA) United States $0.513B 0.00
Third Harmonic Bio (THRD) United States $0.510B 0.00
GRAIL (GRAL) United States $0.507B 0.00
Absci (ABSI) United States $0.507B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.506B 0.00
Voyager Therapeutics (VYGR) United States $0.504B 0.00
MaxCyte (MXCT) United States $0.502B 0.00
Oculis Holding AG (OCS) Switzerland $0.471B 0.00
Northwest Biotherapeutics (NWBO) United States $0.470B 0.00
Editas Medicine (EDIT) United States $0.465B 0.00
C4 Therapeutics (CCCC) United States $0.447B 0.00
Q32 Bio (QTTB) United States $0.433B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.431B 0.00
Kyverna Therapeutics (KYTX) United States $0.424B 0.00
Precigen (PGEN) United States $0.424B 0.00
Ocugen (OCGN) United States $0.422B 0.00
Revance Therapeutics (RVNC) United States $0.409B 0.00
Anika Therapeutics (ANIK) United States $0.407B 348.75
UniQure (QURE) Netherlands $0.405B 0.00
EnGene Holdings (ENGN) United States $0.397B 0.00
AC Immune (ACIU) Switzerland $0.387B 0.00
Alto Neuroscience (ANRO) United States $0.386B 0.00
TScan Therapeutics (TCRX) United States $0.384B 0.00
Urogen Pharma (URGN) United States $0.383B 0.00
Poseida Therapeutics (PSTX) United States $0.383B 0.00
Sutro Biopharma (STRO) United States $0.367B 0.00
Nautilus Biotechnology (NAUT) United States $0.366B 0.00
Inozyme Pharma (INZY) United States $0.361B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.360B 0.00
Solid Biosciences (SLDB) United States $0.357B 0.00
Nkarta (NKTX) United States $0.348B 0.00
Cabaletta Bio (CABA) United States $0.347B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.343B 0.00
Kamada (KMDA) Israel $0.341B 25.83
XOMA Royalty (XOMA) United States $0.340B 0.00
Atea Pharmaceuticals (AVIR) United States $0.330B 0.00
Amarin (AMRN) Ireland $0.327B 0.00
MeiraGTx Holdings (MGTX) United States $0.325B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.317B 0.00
ALX Oncology Holdings (ALXO) United States $0.315B 0.00
Cartesian Therapeutics (RNAC) United States $0.311B 0.00
Jasper Therapeutics (JSPR) United States $0.310B 0.00
Scilex Holding (SCLX) United States $0.305B 0.00
Tenaya Therapeutics (TNYA) United States $0.305B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.300B 0.00
Design Therapeutics (DSGN) United States $0.297B 0.00
Inovio Pharmaceuticals (INO) United States $0.293B 0.00
Alimera Sciences (ALIM) United States $0.292B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.269B 0.00
Codexis (CDXS) United States $0.261B 0.00
Prima BioMed (IMMP) Australia $0.258B 0.00
Mersana Therapeutics (MRSN) United States $0.257B 0.00
Gossamer Bio (GOSS) United States $0.253B 0.00
CorMedix Inc (CRMD) United States $0.250B 0.00
Zura Bio (ZURA) United States $0.248B 0.00
2seventy Bio (TSVT) United States $0.246B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.236B 0.00
Generation Bio (GBIO) United States $0.234B 0.00
Molecular Partners AG (MOLN) Switzerland $0.233B 0.00
ChromaDex (CDXC) United States $0.232B 0.00
Trevi Therapeutics (TRVI) United States $0.229B 0.00
Caribou Biosciences (CRBU) United States $0.225B 0.00
XBiotech (XBIT) United States $0.221B 0.00
23andMe Holding (ME) United States $0.216B 0.00
Shattuck Labs (STTK) United States $0.210B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.209B 0.00
Greenwich LifeSciences (GLSI) United States $0.208B 0.00
Ventyx Biosciences (VTYX) United States $0.208B 0.00
G1 Therapeutics (GTHX) United States $0.204B 0.00
Oncobiologics (OTLK) United States $0.200B 0.00
GENFIT S.A (GNFT) France $0.200B 0.00
Seres Therapeutics (MCRB) United States $0.200B 0.00
Candel Therapeutics (CADL) United States $0.199B 0.00
Biomea Fusion (BMEA) United States $0.199B 0.00
Inhibrx Biosciences (INBX) $0.199B 0.00
Coherus BioSciences (CHRS) United States $0.197B 0.00
Renovaro (RENB) United States $0.193B 0.00
Lifecore Biomedical (LFCR) United States $0.190B 0.00
Rezolute (RZLT) United States $0.188B 0.00
Puma Biotechnology (PBYI) United States $0.185B 11.61
FibroBiologics (FBLG) United States $0.183B 0.00
Sangamo Therapeutics (SGMO) United States $0.179B 0.00
ScPharmaceuticals (SCPH) United States $0.178B 0.00
Adherex Technologies (FENC) United States $0.178B 217.00
Adocia (ADOCY) France $0.178B 0.00
Vigil Neuroscience (VIGL) United States $0.174B 0.00
Skye Bioscience (SKYE) United States $0.173B 0.00
Innate Pharma S.A (IPHA) France $0.172B 0.00
Kodiak Sciences (KOD) United States $0.171B 0.00
INmune Bio (INMB) United States $0.170B 0.00
Adverum Biotechnologies (ADVM) United States $0.170B 0.00
Repare Therapeutics (RPTX) Canada $0.167B 0.00
Alpha Teknova (TKNO) United States $0.167B 0.00
Syros Pharmaceuticals (SYRS) United States $0.166B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.161B 0.00
Elevation Oncology (ELEV) United States $0.160B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.160B 0.00
Invivyd (IVVD) United States $0.158B 0.00
DiaMedica Therapeutics (DMAC) United States $0.156B 0.00
ATyr Pharma (ATYR) United States $0.153B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.153B 0.00
Compass Therapeutics (CMPX) United States $0.149B 0.00
Rani Therapeutics Holdings (RANI) United States $0.148B 0.00
X4 Pharmaceuticals (XFOR) United States $0.145B 0.00
PDS Biotechnology (PDSB) United States $0.142B 0.00
BioStem Technologies (BSEM) $0.139B 0.00
Agenus (AGEN) United States $0.138B 0.00
Seer (SEER) United States $0.134B 0.00
Bluebird Bio (BLUE) United States $0.133B 0.00
Opthea (OPT) Australia $0.131B 0.00
Adicet Bio (ACET) United States $0.131B 0.00
Immunic (IMUX) United States $0.131B 0.00
Adlai Nortye (ANL) Cayman Islands $0.129B 0.00
Cellectis S.A (CLLS) France $0.128B 0.00
Nuvectis Pharma (NVCT) United States $0.127B 0.00
Athira Pharma (ATHA) United States $0.127B 0.00
Annovis Bio (ANVS) United States $0.122B 0.00
Akoya Biosciences (AKYA) United States $0.121B 0.00
Inventiva S.A (IVA) France $0.120B 0.00
Werewolf Therapeutics (HOWL) United States $0.119B 0.00
CytomX Therapeutics (CTMX) United States $0.117B 7.50
Rapt Therapeutics (RAPT) United States $0.117B 0.00
TELA Bio (TELA) United States $0.113B 0.00
Semper Paratus Acquisition (TVGN) United States $0.113B 0.00
Adagene (ADAG) China $0.111B 0.00
I-Mab (IMAB) China $0.110B 0.00
Coya Therapeutics (COYA) United States $0.107B 0.00
Omega Therapeutics (OMGA) United States $0.106B 0.00
Cardiff Oncology (CRDF) United States $0.105B 0.00
Sagimet Biosciences (SGMT) United States $0.104B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.102B 0.00
VistaGen Therapeutics (VTGN) United States $0.100B 0.00
BioHarvest Sciences (CNVCF) Canada $0.098B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.098B 0.00
Cognition Therapeutics (CGTX) United States $0.095B 0.00
HilleVax (HLVX) United States $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.093B 0.00
Eton Pharmaceuticals (ETON) United States $0.092B 89.50
Elutia (ELUT) United States $0.092B 0.00
Checkpoint Therapeutics (CKPT) United States $0.092B 0.00
InflaRx (IFRX) Germany $0.090B 0.00
DBV Technologies S.A (DBVT) France $0.090B 0.00
Benitec Biopharma (BNTC) United States $0.088B 0.00
LENZ Therapeutics (LENZ) United States $0.087B 0.00
Clearside Biomedical (CLSD) United States $0.087B 0.00
CervoMed (CRVO) United States $0.087B 0.00
IO Biotech (IOBT) Denmark $0.085B 0.00
Boundless Bio (BOLD) United States $0.083B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Instil Bio (TIL) United States $0.081B 0.00
Allakos (ALLK) United States $0.081B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.080B 0.00
Estrella Immunopharma (ESLA) United States $0.080B 0.00
AN2 Therapeutics (ANTX) United States $0.080B 0.00
Chimerix (CMRX) United States $0.080B 0.00
Oncolytics Biotech (ONCY) Canada $0.079B 0.00
Kronos Bio (KRON) United States $0.079B 0.00
Affimed (AFMD) Germany $0.078B 0.00
BioAtla (BCAB) United States $0.078B 0.00
Eyenovia (EYEN) United States $0.078B 0.00
Spero Therapeutics (SPRO) United States $0.077B 2.81
BeyondSpring (BYSI) United States $0.077B 0.00
Genenta Science S.p.A (GNTA) Italy $0.076B 0.00
Genelux (GNLX) United States $0.075B 0.00
Ovid Therapeutics (OVID) United States $0.075B 0.00
Verastem (VSTM) United States $0.075B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.073B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.071B 0.00
Gritstone Bio (GRTS) United States $0.071B 0.00
Precision BioSciences (DTIL) United States $0.070B 0.00
Connect Biopharma Holdings (CNTB) United States $0.069B 0.00
Galena Biopharma (SLS) United States $0.068B 0.00
Theratechnologies (THTX) Canada $0.067B 0.00
Earth Science Tech (ETST) United States $0.066B 0.00
Vor Biopharma (VOR) $0.066B 0.00
Intensity Therapeutics (INTS) United States $0.064B 0.00
MediciNova (MNOV) United States $0.064B 0.00
VTv Therapeutics (VTVT) United States $0.064B 0.00
Celularity (CELU) United States $0.061B 0.00
HOOKIPA Pharma (HOOK) United States $0.061B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Enzo Biochem (ENZ) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.059B 0.00
Turnstone Biologics (TSBX) United States $0.059B 0.00
Aerovate Therapeutics (AVTE) United States $0.058B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.057B 0.00
Passage Bio (PASG) United States $0.057B 0.00
Rallybio (RLYB) United States $0.056B 0.00
Leap Therapeutics (LPTX) United States $0.056B 0.00
Aileron Therapeutics (ALRN) United States $0.055B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.055B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.053B 0.00
Lexaria Bioscience (LEXX) Canada $0.053B 0.00
Ocuphire Pharma (OCUP) United States $0.053B 0.00
Elicio Therapeutics (ELTX) United States $0.050B 0.00
Lantern Pharma (LTRN) United States $0.049B 0.00
Atara Biotherapeutics (ATRA) United States $0.049B 0.00
Kezar Life Sciences (KZR) United States $0.049B 0.00
Fortress Biotech (FBIO) United States $0.046B 0.00
NextCure (NXTC) United States $0.046B 0.00
ARCA Biopharma (ABIO) United States $0.046B 0.00
Dyadic (DYAI) United States $0.045B 0.00
LakeShore Biopharma (LSB) China $0.044B 0.00
Ocean Biomedical (OCEA) United States $0.044B 0.00
BioXcel Therapeutics (BTAI) United States $0.043B 0.00
CalciMedica (CALC) United States $0.042B 0.00
Aligos Therapeutics (ALGS) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
Longeveron (LGVN) United States $0.042B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.040B 0.00
OKYO Pharma (OKYO) $0.039B 0.00
Aadi Bioscience (AADI) United States $0.039B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
IN8bio (INAB) United States $0.037B 0.00
Immuneering (IMRX) United States $0.037B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.036B 0.00
Curis (CRIS) United States $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.034B 0.00
Quince Therapeutics (QNCX) United States $0.034B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
Cue Biopharma (CUE) United States $0.033B 0.00
BioAffinity Technologies (BIAF) United States $0.032B 0.00
MiNK Therapeutics (INKT) United States $0.031B 0.00
NKGen Biotech (NKGN) United States $0.031B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
Dare Bioscience (DARE) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Beyond Air (XAIR) United States $0.029B 0.00
Equillium (EQ) United States $0.029B 0.00
Clene (CLNN) United States $0.029B 0.00
Bolt Biotherapeutics (BOLT) United States $0.029B 0.00
Lisata Therapeutics (LSTA) United States $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.026B 0.00
Femasys (FEMY) United States $0.025B 0.00
UNITY Biotechnology (UBX) United States $0.025B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.025B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.024B 0.00
HCW Biologics (HCWB) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
Evogene (EVGN) Israel $0.021B 0.00
Carmell (CTCX) United States $0.021B 0.00
Cara Therapeutics (CARA) United States $0.020B 0.00
Forte Biosciences (FBRX) United States $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Apollomics (APLM) United States $0.020B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.020B 0.00
Synlogic (SYBX) United States $0.020B 0.00
KALA BIO (KALA) United States $0.019B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Sensei Biotherapeutics (SNSE) United States $0.017B 0.00
Evaxion Biotech (EVAX) Denmark $0.016B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
VBI Vaccines (VBIV) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.016B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Lumos Pharma (LUMO) United States $0.015B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
BRIACELL THERAP (BCTX) Canada $0.014B 0.00
Kintara Therapeutics (KTRA) United States $0.014B 0.00
Monopar Therapeutics (MNPR) United States $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
Vaccinex (VCNX) United States $0.011B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.011B 0.00
Aptose Biosciences (APTO) Canada $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Purple Biotech (PPBT) Israel $0.010B 0.00
NuCana (NCNA) United Kingdom $0.010B 0.00
Eterna Therapeutics (ERNA) United States $0.010B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Silo Pharma (SILO) United States $0.009B 0.00
Organovo Holdings (ONVO) United States $0.008B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Elevai Labs (ELAB) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
Kineta (KA) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.008B 0.00
ANEW Medical (WENA) United States $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Telesis Bio (TBIO) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
GeoVax Labs (GOVX) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Notable Labs (NTBL) United States $0.006B 0.00
Bionomics (BNOX) Australia $0.006B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Psyence Biomedical (PBM) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Hoth Therapeutics (HOTH) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Virios Therapeutics (VIRI) United States $0.004B 0.00
Trevena (TRVN) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Allarity Therapeutics (ALLR) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Portage Biotech (PRTG) $0.003B 0.00
Ensysce Biosciences (ENSC) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Invo BioScience (INVO) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
ARAVIVE, INC (ARAV) United States $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Cingulate (CING) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
CNS Pharmaceuticals (CNSP) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Seelos Therapeutics (SEEL) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
Compugen (CGEN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00